Skip to content
TheNote.app
Download_on_the_App_Store_Badge_US-UK_RGB_blk_4SVG_092917
GSK press releases
FDA grants priority review of Nucala for patients with Hypereosinophilic Syndrome (HES)
An approval would give Nucala a third indication in an eosinophil-driven disease
gsk.com
gsk.com
